1. Home
  2. AGIG vs MIRA Comparison

AGIG vs MIRA Comparison

Compare AGIG & MIRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Abundia Global Impact Group Inc. Common stock

AGIG

Abundia Global Impact Group Inc. Common stock

N/A

Current Price

$1.03

Market Cap

41.8M

Sector

Energy

ML Signal

N/A

Logo MIRA Pharmaceuticals Inc.

MIRA

MIRA Pharmaceuticals Inc.

HOLD

Current Price

$0.99

Market Cap

43.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AGIG
MIRA
Founded
N/A
2020
Country
United States
United States
Employees
2
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
41.8M
43.7M
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
AGIG
MIRA
Price
$1.03
$0.99
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
130.1K
61.8K
Earning Date
05-19-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.84
$0.90
52 Week High
$5.31
$2.45

Technical Indicators

Market Signals
Indicator
AGIG
MIRA
Relative Strength Index (RSI) 49.96 52.55
Support Level $0.92 $0.91
Resistance Level $1.26 $1.01
Average True Range (ATR) 0.08 0.05
MACD 0.01 0.00
Stochastic Oscillator 77.08 53.66

Price Performance

Historical Comparison
AGIG
MIRA

About AGIG Abundia Global Impact Group Inc. Common stock

Abundia Global Impact Group Inc. is a technology solutions company operating in recycling, renewable energy, environmental change, fuels, and chemicals sectors, mainly focused on low-carbon energy solutions. The company uses waste plastics and biomass to produce crude or drop-in alternatives to fossil-derived energy, fuels, and chemicals through proprietary, licensed, and commercialized technologies, forming a complete process. It operates through its subsidiary and integrates feedstocks, technology, and off-take partners into a complete commercial chain. Its segments include Oil and Gas (O&G), which generates maximum revenue, and Renewables, which consists of its low-carbon fuels and renewable chemicals business.

About MIRA MIRA Pharmaceuticals Inc.

Mira Pharmaceuticals Inc is a clinical-stage pharmaceutical development company focused on developing novel oral small-molecule therapeutics for neurologic, neuropsychiatric, metabolic, and inflammatory disorders. The company's pipeline includes three product candidates: Ketamir-2, MIRA-55, and SKNY-1, three drug candidates designed to address unmet medical needs across neuropathic and inflammatory pain, central nervous system disorders, and metabolic and behavioral conditions. The company operates as a single operating and reportable segment.

Share on Social Networks: